Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2026)

Camp4 Therapeutics' Non Operating Income history spans 3 years, with the latest figure at -$27.5 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 3743.44% to -$27.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$27.1 million, a 2886.71% decrease, with the full-year FY2025 number at -$27.8 million, down 2247.11% from a year prior.
  • Non Operating Income hit -$27.5 million in Q4 2025 for Camp4 Therapeutics, down from -$71000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for CAMP hit a ceiling of $755000.0 in Q4 2024 and a floor of -$27.5 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$2.5 million across 3 years, with a median of $251000.0 in 2024.
  • The widest YoY moves for Non Operating Income: up 404.14% in 2025, down 3743.44% in 2025.
  • Tracing CAMP's Non Operating Income over 3 years: stood at $486000.0 in 2023, then skyrocketed by 55.35% to $755000.0 in 2024, then tumbled by 3743.44% to -$27.5 million in 2025.
  • Business Quant data shows Non Operating Income for CAMP at -$27.5 million in Q4 2025, -$71000.0 in Q3 2025, and $441000.0 in Q2 2025.